Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib
Gavric, Ana Ursula, Ocvirk, Janja, Mekjavic, Polona Jaki
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma
Moltara, Maja Ebert, Novakovic, Srdjan, Boc, Marko, Bucic, Marina, Rebersek, Martina, Zadnik, Vesna, Ocvirk, Janja
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Mesti, Tanja, Ebert Moltara, Maja, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
Rebersek, Martina, Mesti, Tanja, Boc, Marko, Ocvirk, Janja
Paratesticular adenocarcinoma: unusual presentation of metastasis of pancreatic cancer
Ocvirk, Janja, Šeruga, Boštjan
Nuclear magnetic resonance metabolic fingerprint of bevacizumab in mutant IDH1 glioma cells
Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
Ocvirk, Janja
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer
Oblak, Irena, Velenik, Vaneja, Anderluh, Franc, Mozina, Barbara, Ocvirk, Janja
Advances in the treatment of metastatic colorectal carcinoma
Ocvirk, Janja
Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
Oblak, Irena, Anderluh, Franc, Velenik, Vaneja, Mozina, Barbara, Ocvirk, Janja, Ciric, Eva, Podvrsnik, Natasa
The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement
Mesti, Tanja, Boshkoska, Biljana Mileva, Kos, Mitja, Tekavčič, Metka, Ocvirk, Janja
The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) – a real- life data report 2013–2018
Mesti, Tanja, Rebersek, Martina, Ocvirk, Janja